<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Jeff Paroddy</title><link>https://jeffparoddy.com/</link><atom:link href="https://jeffparoddy.com/feed.xml" rel="self" type="application/rss+xml"/><description>AI, health and longevity. Evidence, not hype.</description><language>en-us</language><item><title>Ukraine&#x27;s Starlink 100 mph Cap: Who Holds the Off Switch</title><link>https://jeffparoddy.com/articles/starlink-ukraine-speed-cap-who-controls/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/starlink-ukraine-speed-cap-who-controls/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Science</category><description>Kyiv blames SpaceX, Musk points to Washington, and Eutelsat jumped about 23% in Paris. The fight over one speed limit exposes who really controls the satellites.</description></item><item><title>U.S. Social Security COLA: Why 2027&#x27;s Raise Is 3.6%, Not 3.9%</title><link>https://jeffparoddy.com/articles/social-security-cola-2027-cpi-w/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/social-security-cola-2027-cpi-w/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Economy</category><description>The legal formula averages July to September, so September&#x27;s gasoline spike counts for only a third, and the Medicare premium that trims the raise is not set yet.</description></item><item><title>AUF1 Gene Therapy Limited Muscle Loss After Injury in Mice</title><link>https://jeffparoddy.com/articles/auf1-muscle-injury-mice/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/auf1-muscle-injury-mice/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Mice kept near normal strength after a severe muscle injury when given extra AUF1, by virus or by mRNA. Two authors cofounded the company developing it, and no human has received it.</description></item><item><title>An Oral Pill for Angioedema Attacks: Relief in 1.3 Hours</title><link>https://jeffparoddy.com/articles/deucrictibant-oral-hae-attacks/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/deucrictibant-oral-hae-attacks/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>A crossover trial in a rare disease, funded by the drugmaker: each patient treated one attack with the pill and one with placebo. The result is large and the analysis smaller than the enrollment.</description></item><item><title>A Parkinson&#x27;s Pill That Skips Dopamine Cut Off Time by 37 Minutes</title><link>https://jeffparoddy.com/articles/solengepras-parkinsons-arise/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/solengepras-parkinsons-arise/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>A new mechanism, a positive primary endpoint and a modest effect size. Everything here comes from a company release and a congress talk, not a peer reviewed paper.</description></item><item><title>A Long COVID Trial Was Retracted. Half of It Still Stands</title><link>https://jeffparoddy.com/articles/long-covid-revive-retraction/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/long-covid-revive-retraction/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Evidence Guides</category><description>A dose cut and an early stop were applied in the trial but left out of the analysis. The fix downgraded one drug and left the other untouched.</description></item><item><title>Reading Iambic&#x27;s S-1: An AI Drug IPO, Risk Factors First</title><link>https://jeffparoddy.com/articles/iambic-s1-ai-drug-ipo/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/iambic-s1-ai-drug-ipo/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>One drug in early clinical testing, a $245 million accumulated deficit, and a platform the company itself calls unproven. The prospectus is more candid than the headlines.</description></item><item><title>Seven FDA Decisions Due by Christmas, and the Trials Behind Them</title><link>https://jeffparoddy.com/articles/fda-decisions-q4-2026/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/fda-decisions-q4-2026/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Every date below comes from the company itself. CagriSema has no published goal date, only a quarter. One file arrives after an advisory committee voted 9 to 3 against.</description></item><item><title>Anthropic Moves Into Biology: What Is Announced vs Shown</title><link>https://jeffparoddy.com/articles/anthropic-life-sciences-claims/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/anthropic-life-sciences-claims/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>Four launches in three months. One produced a preprint about an enzyme system whose function is still unknown. The rest are access rules, pilots and promises.</description></item><item><title>Where Your Arm Rests Can Add 6 Points to a Blood Pressure Reading</title><link>https://jeffparoddy.com/articles/home-blood-pressure-arm-position/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/home-blood-pressure-arm-position/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Lap: +3.9 mmHg systolic. Arm at your side: +6.5. A randomized trial measured the couch error, and the fix is a table and five quiet minutes.</description></item><item><title>Semaglutide&#x27;s Heart Benefit Is Not Just About Weight Loss</title><link>https://jeffparoddy.com/articles/semaglutide-heart-benefit-beyond-weight/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/semaglutide-heart-benefit-beyond-weight/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Known risk factors explain at most about half of the 20% drop in heart events, and the frailest patients still benefit. Widening eligibility to a BMI of 25 is a different question.</description></item><item><title>Orforglipron Worked Across Menopause Stages, With One Asterisk</title><link>https://jeffparoddy.com/articles/orforglipron-menopause-stages/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/orforglipron-menopause-stages/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Women lost 12.8% to 14.4% of their weight on the top dose without diabetes. The diabetes trial tells a shakier story, built partly on a subgroup of 10 women.</description></item><item><title>One Insulin Shot a Week: What the Efsitora Approval Covers</title><link>https://jeffparoddy.com/articles/weekly-insulin-efsitora-approval/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/weekly-insulin-efsitora-approval/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Efsitora matched daily insulin on HbA1c in four trials and trades 365 injections for 52. In type 1 diabetes, severe lows were three times as common, which is why the label stops at type 2.</description></item><item><title>Patch Pumps, Implanted Sensors and a Year of Omnipod 5 Data</title><link>https://jeffparoddy.com/articles/insulin-pumps-mint-omnipod-eversense/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/insulin-pumps-mint-omnipod-eversense/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Omnipod 5 users kept 4.3 extra hours a day in range for a year. Beta Bionics&#x27; Mint is cleared but launches in 2027, and its new algorithm still awaits the FDA.</description></item><item><title>Eight Hours or Nine? What Eating Window Trials Actually Show</title><link>https://jeffparoddy.com/articles/eating-window-8-vs-9-hours/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/eating-window-8-vs-9-hours/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Shorter windows meant a few more pounds lost over months. Against a dietitian, a 9 hour window did no better on blood sugar, and both groups lost the same weight.</description></item><item><title>Half of Young Adults in RESET Put Type 2 Diabetes in Remission</title><link>https://jeffparoddy.com/articles/reset-remission-early-type-2-diabetes/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/reset-remission-early-type-2-diabetes/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>27 of 50 reached remission in 24 weeks, against 2 of 46 on usual care, and they lost fat without losing lean mass. A 1.6 million patient study shows the stakes of waiting.</description></item><item><title>AI Worms on $55 TV Boxes: What Anthropic Actually Showed</title><link>https://jeffparoddy.com/articles/self-replicating-ai-tv-boxes/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/self-replicating-ai-tv-boxes/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>One open model copied itself across a test network with a deliberately easy exploit. The claim that small models will match it by year end rests on a trend line.</description></item><item><title>An AI Epilepsy Monitor Learned From Patients. False Alarms Fell 77.8% in a Replay</title><link>https://jeffparoddy.com/articles/ai-epilepsy-monitor-false-alarms/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/ai-epilepsy-monitor-false-alarms/</guid><pubDate>Wed, 14 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>Patient feedback retrained a seizure detector and cut false alarms by a median 77.8% in 13 inpatients. The retraining was tested in a replay, not live.</description></item><item><title>Artemis II Saw Impact Flashes and a Moon That Isn&#x27;t Gray</title><link>https://jeffparoddy.com/articles/artemis-ii-moon-not-gray/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/artemis-ii-moon-not-gray/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Science</category><description>Three astronauts spotted five pinprick impact flashes during an eclipse, and described a Moon tinted brown, green and blue. A preliminary report.</description></item><item><title>Why Claude Hides Its Reasoning: The Distillation Arms Race</title><link>https://jeffparoddy.com/articles/anthropic-distillation-defenses/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/anthropic-distillation-defenses/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>A copy trained on Claude&#x27;s full reasoning scored 80.4% on a coding test, 71.8% on summaries. Anthropic says theft is down 90 to 99%, by its own count.</description></item><item><title>Can Brain Training Delay Dementia? A 20 Year Trial, Read Closely</title><link>https://jeffparoddy.com/articles/brain-training-dementia-active-trial/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/brain-training-dementia-active-trial/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>One arm of a 1990s trial saw fewer dementia diagnoses over 20 years. Five others did not, and the statistics are being argued in public.</description></item><item><title>K2-18b&#x27;s Life Signal: What Webb Saw and What It Didn&#x27;t</title><link>https://jeffparoddy.com/articles/k2-18b-life-signal-explained/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/k2-18b-life-signal-explained/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Science</category><description>A three sigma hint of dimethyl sulfide made headlines. Most independent reanalyses of the same data don&#x27;t find it, and the gas exists on a comet too.</description></item><item><title>AI Is Breaking the First Rung of the Career Ladder</title><link>https://jeffparoddy.com/articles/ai-entry-level-jobs-first-rung/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/ai-entry-level-jobs-first-rung/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>Employment of 22 to 25 year olds in the most AI exposed jobs sits 19% below trend. The cause is fewer hires, not more layoffs.</description></item><item><title>Nvidia&#x27;s $530 Billion Isn&#x27;t Hidden Debt. Read the 10-Q</title><link>https://jeffparoddy.com/articles/nvidia-530-billion-commitments/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/nvidia-530-billion-commitments/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Economy</category><description>Three tables add up to $530 billion. Most of it is a shopping list. The part worth watching is a $105 billion guarantee for one OpenAI site.</description></item><item><title>Gooier Marine Snow Locks Away More Ocean Carbon</title><link>https://jeffparoddy.com/articles/marine-snow-viscosity-carbon/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/marine-snow-viscosity-carbon/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Science</category><description>Bacteria struggle to break into the gooiest marine snow, so it sinks deeper. The headline sixfold carbon figure comes from simulations, not the sea.</description></item><item><title>Is Antimatter Escaping the Milky Way? Read the Sigma First</title><link>https://jeffparoddy.com/articles/milky-way-antimatter-escape/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/milky-way-antimatter-escape/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Science</category><description>Faint 511 keV hotspots match gas clouds beyond the galaxy. If real, the Milky Way makes even more antimatter than anyone can explain. If.</description></item><item><title>The Economics Nobel Behind Every Fed Rate Decision</title><link>https://jeffparoddy.com/articles/nobel-economics-hall-woodford/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/nobel-economics-hall-woodford/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Economy</category><description>Hall showed why spending changes are unpredictable. Woodford built the model central banks run. Together they explain why the Fed talks so much.</description></item><item><title>Google&#x27;s 890 MW Nuclear Deal Builds No New Reactor</title><link>https://jeffparoddy.com/articles/google-constellation-nuclear-uprates/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/google-constellation-nuclear-uprates/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Science</category><description>890 MW of new power from upgrades at 11 existing units, first by 2028. The other 2,700 MW in the headline was already on the grid.</description></item><item><title>One Gentoo Penguin or Four? Genomes Split the Species</title><link>https://jeffparoddy.com/articles/gentoo-penguins-four-species/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/gentoo-penguins-four-species/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Science</category><description>Genomes from ten colonies split the gentoo into four lineages. Three may lose most of their habitat by 2050, masked by one that is thriving.</description></item><item><title>The Free AI Tutor That Lowered Grades</title><link>https://jeffparoddy.com/articles/ai-tutor-lowered-grades/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/ai-tutor-lowered-grades/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>A randomized trial of 2,379 students. The tutor was free, patient, and built on GPT-4o. Grades fell anyway.</description></item><item><title>Strokes Before 55 Nearly Doubled. Heart Attacks Went the Other Way</title><link>https://jeffparoddy.com/articles/young-strokes-rising/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/young-strokes-rising/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Cincinnati counted 2,076 first strokes in adults under 55: the rate rose from 34 to 62 per 100,000. In Oxford, young heart attacks fell over the same years.</description></item><item><title>Lp(a): The Heart Risk Factor Science Still Can&#x27;t Treat</title><link>https://jeffparoddy.com/articles/lpa-horizon-pelacarsen/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/lpa-horizon-pelacarsen/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Pelacarsen lowered Lp(a) in 8,323 HORIZON patients, but heart attacks and strokes did not fall. Why that gap between biomarker and outcome matters.</description></item><item><title>GPT-6 Sol, Sonnet 5.5, Astra Shelved: September&#x27;s Models, Tested</title><link>https://jeffparoddy.com/articles/september-ai-models-benchmarked/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/september-ai-models-benchmarked/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>GPT-6 Sol got cheaper without getting smarter, Sonnet 5.5 got much smarter but not cheaper at full effort, and Astra 6.1 never shipped.</description></item><item><title>Diet Soda Matched Water for Weight. The Word “Equivalent” Didn’t</title><link>https://jeffparoddy.com/articles/diet-soda-water-switch-trial/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/diet-soda-water-switch-trial/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Evidence Guides</category><description>In the SWITCH trial, diet drinkers lost 4.8 kg in two years and water drinkers 3.7 kg, but the way it proved sameness is the real lesson.</description></item><item><title>Helping Others Slowed Cognitive Decline in People Carrying the Alzheimer&#x27;s Risk Gene</title><link>https://jeffparoddy.com/articles/volunteering-apoe4-cognitive-decline/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/volunteering-apoe4-cognitive-decline/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>A free behavior, a few hours a week, and a slower slope of decline for the gene that usually steepens it. The data are observational, and the paper says so.</description></item><item><title>The First PCSK9 Pill Is Here. The Proof Still Comes From a Shot</title><link>https://jeffparoddy.com/articles/oral-pcsk9-pill-apob-target/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/oral-pcsk9-pill-apob-target/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>A daily tablet now cuts LDL by more than half, while the injectable version of the same drug class was linked to 20% fewer deaths in people with no prior heart attack.</description></item><item><title>Your Sleep Tracker Knows How Long You Slept. Not How Deeply</title><link>https://jeffparoddy.com/articles/what-sleep-trackers-really-measure/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/what-sleep-trackers-really-measure/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Every tracker in the lab studies could tell when people were asleep; none could reliably say how deeply, least of all in older adults and patients.</description></item><item><title>How to Read a Health Study in 5 Minutes</title><link>https://jeffparoddy.com/articles/read-health-study-in-5-minutes/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/read-health-study-in-5-minutes/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Evidence Guides</category><description>Six checks: design, endpoint, absolute effect, population, status and funding, limits. The house method, in the open.</description></item><item><title>Retatrutide Takes Weight Off. Viking Bets a Monthly Shot Keeps It</title><link>https://jeffparoddy.com/articles/retatrutide-viking-monthly-maintenance/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/retatrutide-viking-monthly-maintenance/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Retatrutide&#x27;s 20.8% assumes nobody quit, and Viking&#x27;s 90% comes from a group of 11. The numbers behind the two biggest obesity drug headlines of September.</description></item><item><title>Deep Sleep and Alzheimer&#x27;s: What Two New Studies Can and Can&#x27;t Say</title><link>https://jeffparoddy.com/articles/deep-sleep-tau-alzheimers/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/deep-sleep-tau-alzheimers/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>As tau builds in healthy older brains, deep sleep waves stop traveling and memory slips. A strong signal, but nobody yet knows which comes first.</description></item><item><title>Rogue AI Agents in September: What Was Proven, What Was Claimed</title><link>https://jeffparoddy.com/articles/offensive-ai-agents-fact-check/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/offensive-ai-agents-fact-check/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>Four AI agent security stories made September&#x27;s headlines, and they rest on four very different grades of evidence.</description></item><item><title>Diet and Exercise Moved 16 Aging Clocks. Supplements Didn’t</title><link>https://jeffparoddy.com/articles/diet-exercise-beat-supplements-clocks/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/diet-exercise-beat-supplements-clocks/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>A Yale analysis of 51 studies finds diet and exercise move aging clocks reliably, if modestly, while over the counter supplements barely register.</description></item><item><title>AI Eye Screening in Tanzania Nearly Doubled Specialist Follow Up in a Randomized Trial</title><link>https://jeffparoddy.com/articles/ai-eye-screening-tanzania-followup/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/ai-eye-screening-tanzania-followup/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>The win was not a benchmark score. It was people with sight threatening eye disease actually reaching a specialist, and reaching one weeks sooner.</description></item><item><title>AI Layoffs Lead the Headlines. They&#x27;re Under 1% of Layoffs</title><link>https://jeffparoddy.com/articles/ai-layoffs-by-the-numbers/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/ai-layoffs-by-the-numbers/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>Challenger counts 120,136 announced cuts blamed on AI in 2026. Federal data counts about 1.6 million layoffs every month. Both numbers are true.</description></item><item><title>400 Scientists Want a Referee for Advanced AI</title><link>https://jeffparoddy.com/articles/ai-oversight-body/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/ai-oversight-body/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>Hinton, Bengio and about 400 colleagues are asking for an international body to oversee the most capable AI systems. A public call, not yet a policy.</description></item><item><title>Aprocitentan: Another Dial for Hard to Control Blood Pressure</title><link>https://jeffparoddy.com/articles/aprocitentan-precision/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/aprocitentan-precision/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Against placebo, the endothelin blocker lowered systolic pressure by about 4 mmHg on top of three drugs. New post hoc data on obesity and kidney risk.</description></item><item><title>Biological Age Claims Need More Than One Clock</title><link>https://jeffparoddy.com/articles/biological-age-clocks/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/biological-age-clocks/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>A Yale reanalysis of 12 epigenetic clocks says single clock drops don&#x27;t reproduce. Then come the claims: GLP-1s, a skin cream, 2 to 3 years younger.</description></item><item><title>CagriSema and EloraTZP Both Beat Tirzepatide. Read the Doses</title><link>https://jeffparoddy.com/articles/cagrisema-eloratzp-vs-tirzepatide/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/cagrisema-eloratzp-vs-tirzepatide/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Novo won at the low end of the dose range, 12.4 versus 9.1 percent. Lilly won at the top, 23.3 versus 14.8, and lost up to one patient in four to side effects.</description></item><item><title>Myostatin Blockers Cut GLP-1 Muscle Loss. Strength Is Unproven</title><link>https://jeffparoddy.com/articles/glp1-muscle-myostatin-antibodies/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/glp1-muscle-myostatin-antibodies/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Trevogrumab and apitegromab saved kilograms of lean tissue in phase 2 trials, but no study has yet shown that it makes anyone stronger.</description></item><item><title>The Lp(a) Test Everyone Should Get Once, and What It Can&#x27;t Tell You</title><link>https://jeffparoddy.com/articles/lpa-test-once-in-a-lifetime/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/lpa-test-once-in-a-lifetime/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>One blood test for life sounds simple, but this year&#x27;s research shows the result can move, the risk has no clean cutoff, and no Lp(a) drug has proven it saves hearts.</description></item><item><title>Muscle Without Meat After 55: What the IMPACT Trial Found</title><link>https://jeffparoddy.com/articles/muscle-without-meat-impact/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/muscle-without-meat-impact/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Twelve weeks of lifting: vegetarians gained 0.38 kg of limb muscle, omnivores 0.66 kg. The trial could not show the two diets were equivalent.</description></item><item><title>Muse Wonder Full Lands Just Behind Opus 5.5</title><link>https://jeffparoddy.com/articles/muse-wonder-benchmark/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/muse-wonder-benchmark/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>AI at Work</category><description>Meta&#x27;s new flagship scores 56 on an independent index, two points behind Claude Opus 5.5. And the stronger model is not the one you can call today.</description></item><item><title>A GLP-1 Pill Against Insulin: What ACHIEVE-4 Proved for the Heart</title><link>https://jeffparoddy.com/articles/orforglipron-vs-insulin-glargine/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/orforglipron-vs-insulin-glargine/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Orforglipron cleared a heart safety bar against insulin glargine, 4.2 versus 5.0 percent, and posted a mortality gap the trial was never built to prove.</description></item><item><title>The Pill Duel: Orforglipron Beats Oral Semaglutide Head to Head</title><link>https://jeffparoddy.com/articles/orforglipron-vs-semaglutide/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/orforglipron-vs-semaglutide/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>ACHIEVE-3, 1,698 adults, 52 weeks: in the primary analysis HbA1c fell 1.91 points against 1.47. A real head to head, run by one of the duelists.</description></item><item><title>The Race to Keep Muscle on GLP-1s Reaches Phase 2</title><link>https://jeffparoddy.com/articles/sironax-forge-lm/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/sironax-forge-lm/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>Sironax&#x27;s FORGE-LM trial is half enrolled. The endpoint is body composition, which is the right question. Enrollment, though, is not a result.</description></item><item><title>Your Body Clock Leaves a Signature on Your Wrist</title><link>https://jeffparoddy.com/articles/wrist-rhythms-obesity/</link><guid isPermaLink="true">https://jeffparoddy.com/articles/wrist-rhythms-obesity/</guid><pubDate>Tue, 13 Oct 2026 12:00:00 +0000</pubDate><category>Body &amp; Longevity</category><description>809 adults, seven days of wrist sensors: robust temperature rhythms tracked with better metabolic markers, light with lower triglycerides. Association only.</description></item></channel></rss>